Press Releases

Abogen Received Dual IND Approvals for KRAS mRNA Vaccine in China and the United States

Abogen Received FDA IND Approval for KRAS mRNA Vaccine

Abogen Received IND Approval for mRNA Shingles Vaccine

Featuring Proprietary Nucleoside Base Modification, Abogen Received IND Approval for Lyophilized mRNA Vaccine Candidate

Abogen to Present Keynote on Delivery Science at CRS Singapore 2025 Symposium

Dr. Bo Ying from Abogen Biosciences to Present Research Insights at mRNA-Based Therapeutics Summit in Europe

Abogen announced development of Cis-System-based circular RNAs

Abogen’s COVID-19 mRNA Vaccine granted Emergency Use Authorization (EUA) in Indonesia

Abogen Biosciences Closes $300 Million Series C+ Financing

Abogen Biosciences Secures Over $700 Million in Series C Financing to Accelerate its mRNA Platform Across Multiple Vaccines and Diverse Therapeutic Fields